Clinical Trial Update: Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor [Phase 2]

View source ↗

Summary

Phase II trial investigating voxelotor for sickle cell disease focusing on hemolysis-related complications; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Voxelotor (voxelotor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease | Phase 2 | Status: UNKNOWN